Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Proescholdt

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Journal of Neuro-Oncology|December 4, 2024
TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progressionDavid Wasilewski, Tommaso Araceli, Philip Bischoff, et al.
Oligonucleotides|July 20, 2007
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studiesPeter Hau, Piotr Jachimczak, Reimar Schlingensiepen, et al.
Journal of Cancer Research and Clinical Oncology|May 30, 2018
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trialChristina Schaub, Sied Kebir, Nina Junold, et al.
Glia|October 26, 2018
PI3K: A master regulator of brain metastasis-promoting macrophages/microgliaRaquel Blazquez, Darius Wlochowitz, Alexander Wolff, et al.
Journal of Neuro-Oncology|July 21, 2019
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trialSied Kebir, Christina Schaub, Nina Junold, et al.
Nature Medicine|February 28, 2025
Rapid brain tumor classification from sparse epigenomic dataBjörn Brändl, Mara Steiger, Carolin Kubelt, et al.
Neuro-Oncology|November 10, 2017
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastomaNiklas Schäfer, Martin Proescholdt, Joachim P Steinbach, et al.
Neuro-Oncology|November 29, 2020
The genetic landscape of choroid plexus tumors in children and adultsChristian Thomas, Patrick Soschinski, Melissa Zwaig, et al.
Neuro-Oncology|October 11, 2017
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)Dagmar Beier, Martin Proescholdt, Christiane Reinert, et al.
Acta Neuropathologica Communications|May 9, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastomaAyse N Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Journal of Neuro-Oncology|December 4, 2024
TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progressionDavid Wasilewski, Tommaso Araceli, Philip Bischoff, et al.
Oligonucleotides|July 20, 2007
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studiesPeter Hau, Piotr Jachimczak, Reimar Schlingensiepen, et al.
Journal of Cancer Research and Clinical Oncology|May 30, 2018
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trialChristina Schaub, Sied Kebir, Nina Junold, et al.
Glia|October 26, 2018
PI3K: A master regulator of brain metastasis-promoting macrophages/microgliaRaquel Blazquez, Darius Wlochowitz, Alexander Wolff, et al.
Journal of Neuro-Oncology|July 21, 2019
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trialSied Kebir, Christina Schaub, Nina Junold, et al.
Nature Medicine|February 28, 2025
Rapid brain tumor classification from sparse epigenomic dataBjörn Brändl, Mara Steiger, Carolin Kubelt, et al.
Neuro-Oncology|November 10, 2017
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastomaNiklas Schäfer, Martin Proescholdt, Joachim P Steinbach, et al.
Neuro-Oncology|November 29, 2020
The genetic landscape of choroid plexus tumors in children and adultsChristian Thomas, Patrick Soschinski, Melissa Zwaig, et al.
Neuro-Oncology|October 11, 2017
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)Dagmar Beier, Martin Proescholdt, Christiane Reinert, et al.
Acta Neuropathologica Communications|May 9, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastomaAyse N Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, et al.
Pageof 11